Cas9 Expressing Human salivary gland adenoid cystic carcinoma cells

Researchers can use the SSACC-LM-CAS9 cell line to conduct CRISPR-based gene editing research specifically on epithelial tissues from the eye, ear, nose, throat, and oral systems. Because this cell line maintains stable Cas9 expression researchers can achieve accurate and powerful gene editing to knock out, knock in or modify genes which proves essential for understanding gene function and disease pathology. This cell line serves as a research tool for understanding salivary gland cancers and oral cancers among other epithelial-derived diseases. The presence of a hygromycin resistance marker helps scientists identify transfected cells which improves the reliability of their experiments. The cell line serves as a strong platform for high-throughput screening applications while enabling functional genomics investigations and drug discovery research essential for analyzing therapeutic targets and molecular pathways.